274 related articles for article (PubMed ID: 37534382)
1. Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Leary SES; Onar-Thomas A; Fangusaro J; Gottardo NG; Cohen K; Smith A; Huang A; Haas-Kogan D; Fouladi M;
Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30600. PubMed ID: 37534382
[TBL] [Abstract][Full Text] [Related]
2. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
Cacciotti C; Fleming A; Ramaswamy V
J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
[TBL] [Abstract][Full Text] [Related]
3. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
4. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
Plant-Fox AS; O'Halloran K; Goldman S
Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
[TBL] [Abstract][Full Text] [Related]
5. Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.
Gajjar A; Packer RJ; Foreman NK; Cohen K; Haas-Kogan D; Merchant TE;
Pediatr Blood Cancer; 2013 Jun; 60(6):1022-6. PubMed ID: 23255213
[TBL] [Abstract][Full Text] [Related]
6. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
7. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract][Full Text] [Related]
8. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
Robinson GW; Witt H; Resnick A
Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes.
Metzger S; Weiser A; Gerber NU; Otth M; Scheinemann K; Krayenbühl N; Grotzer MA; Guerreiro Stucklin AS
J Neurooncol; 2022 Apr; 157(2):307-317. PubMed ID: 35147892
[TBL] [Abstract][Full Text] [Related]
10. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
Kaneva K; Goldman S
Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
[TBL] [Abstract][Full Text] [Related]
12. Brain tumors: Medulloblastoma, ATRT, ependymoma.
Baliga S; Gandola L; Timmermann B; Gail H; Padovani L; Janssens GO; Yock TI
Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28395. PubMed ID: 32386126
[TBL] [Abstract][Full Text] [Related]
13. Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.
Hart M; Anderson-Mellies A; Beltrami A; Gilani A; Green AL
J Neurooncol; 2022 Apr; 157(2):333-344. PubMed ID: 35175546
[TBL] [Abstract][Full Text] [Related]
14. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
15. [Malignant cerebral tumors in children].
Doz F
Rev Prat; 1993 Nov; 43(17):2187-91. PubMed ID: 8146534
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017.
Niehusmann P; Stensvold E; Leske H; Pietsch T; Goschzik T; Gielen GH; Due-Tønnessen B; Frič R; Nilssen Y; Brandal P
Pediatr Blood Cancer; 2022 Sep; 69(9):e29736. PubMed ID: 35570402
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.
Glod J; Rahme GJ; Kaur H; H Raabe E; Hwang EI; Israel MA
J Pediatr Hematol Oncol; 2016 May; 38(4):249-60. PubMed ID: 26989915
[TBL] [Abstract][Full Text] [Related]
19. Embryonal Tumors of the Central Nervous System: An Update.
Blessing MM; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
[TBL] [Abstract][Full Text] [Related]
20. Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
Foster JB; Griffin C; Rokita JL; Stern A; Brimley C; Rathi K; Lane MV; Buongervino SN; Smith T; Madsen PJ; Martinez D; Delaidelli A; Sorensen PH; Wechsler-Reya RJ; Karikó K; Storm PB; Barrett DM; Resnick AC; Maris JM; Bosse KR
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
